A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

NCT06110923 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostate Hypertrophy(BPH)

Interventions

DRUG: CKD-846
DRUG: D091

Sponsor

Chong Kun Dang Pharmaceutical